09.12.25 -- The Generalist Biotech CEO With Seekyo's Oury Chetboun

In this presentation from the Patients as Partners conference, Carebox CEO Brian Weiss discussed why it’s time to move past per-study custom pre-screeners.

Manufacturers with proven expertise in areas like viral vector production and analytics are needed now more than ever to get breakthrough, deliverable gene editing therapies to patients.

When you're preparing for an IPO, it's important to consider transitioning to a scalable ERP system, enabling your life science company to efficiently handle financial data.

In this 4-part series, learn about AI-driven methods that streamline data mapping and highlight critical issues that allow clinical teams to focus on what truly matters.

Clinical trial success hinges on more than enrollment. The Patient Experience (PX) model delivers sustained, behaviorally intelligent engagement that improves outcomes across the board.

To address challenges such as limited patient awareness, mistrust, and logistical barriers, the industry must embrace technology-driven solutions and community-centered outreach.

AI has a unique ability to process and analyze massive datasets at groundbreaking speeds. By leveraging these capabilities, pharmaceutical companies hope to fundamentally reimagine core aspects of clinical trials.